title: The consequences of 'double examination' for pharmaceutical patent applications in Brazil.
authors.affiliation: Montaury Pimenta, Machado & Vieira de Mello - Partner of the Patent Department, Rio de Janeiro, Brazil.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Salerno
mesh_terms: D001938:Brazil; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
keywords: ANVISA; INPI backlog; patent; pharmaceutical